Vectus Biosystems: Could this drug eventually prevent thousands of deaths?
Listen to ASX-listed Vectus Biosystems CEO Karen Duggan talk to Matt Birney on the Bulls N’ Bears Report about Vectus’ rapidly developing treatment for a condition that is a factor in up to 40 per cent of all deaths.